ALLIANCE SAÚDE E PARTICIPAÇÕES S.A. (“Company” or “Alliança”) (B3: AARL3), in compliance with the provisions of art. 157, § 4.º, of Law No. 6,404, of December 15, 1976, as amended, and in Resolution of the Securities and Exchange Commission No. 44, of August 23, 2021, as amended, and in attention to the Relevant Fact disclosed on May 8, 2024, informs its shareholders and the market in general that, at the Extraordinary General Meeting held on May 29, 2024, the Company’s shareholders decided to withdraw from the agenda all matters contained in the agenda, as proposed by the Company’s management at the Meeting, due to the verification of facts subsequent to the convening of the conclave, regarding divergences with third parties in the interpretation of certain obligations contained in debt issuance deeds of the Company that affect the simple celebration of the Exchange Agreement, carried out on May 3, 2024 by Alliança and Fonte de Saúde Fundo de Investimento Participações Multiestratégia (“Exchange Agreement” and “Fonte de Saúde FIP”, respectively).
The Company’s management clarifies that, although it disagrees with the aforementioned divergent interpretation presented, it understands that the suspension of acts relating to the deliberation and consequent implementation of the operation, at least until such divergences are resolved, constitutes the most appropriate measure to be adopted to preserve the best social interest.
The Company will keep its shareholders and the market informed about any new facts regarding the Exchange.
São Paulo, May 31, 2024.
ALLIANÇA SAÚDE E PARTICIPAÇÕES S.A.